Goodrx Holdings, Inc. Stock Price, News & Analysis

GoodRx (NASDAQ: GDRX) announced the launch of GoodRx Community Link, a new offering for independent community pharmacies, set to debut in June 2025. The platform will enable locally owned pharmacies to directly contract with GoodRx on pricing and manage participation in the company's Integrated Savings Programs (ISP). The initiative implements cost-plus models to provide independent pharmacies with enhanced control over pricing and improved margins.

GoodRx, which serves nearly 30 million consumers and over 1 million healthcare professionals annually, has helped Americans save over $85 billion on medication costs since 2011. The company will host informational webinars on June 3 and 4, 2025, featuring Aaron Crittenden, President of Rx Marketplace, to discuss the new program with independent pharmacy teams.

GoodRx, the leading platform for medication savings in the U.S., has scheduled its first quarter 2025 financial results announcement. The company will release its Q1 2025 results after U.S. markets close on Wednesday, May 7, 2025.

A conference call and webcast with GoodRx management will follow on Thursday, May 8, 2025 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and business outlook. Interested parties can pre-register for the conference call through a provided link to receive dial-in details and a unique passcode.

The call will be webcast live on the company's investor relations website, where presentation materials will be available before the conference. An archived version of the webcast will remain accessible for at least 30 days after the call.

GoodRx (NASDAQ: GDRX) has launched a new e-commerce experience for retail pharmacies, partnering with Midwest retailer Hy-Vee as their initial collaborator. The platform enhances the prescription fulfillment process by:

The system now checks medication inventory, validates prescriptions, and enables online payment before in-store pickup. This innovation aims to streamline pharmacy workflows and improve consumer experience.

According to Wendy Barnes, President and CEO of GoodRx, this initiative addresses friction points at pharmacy counters while supporting retail pharmacy efficiency and profitability. The platform includes features like inventory verification, prescription validation, and flexible payment options including pay-over-time.

This development follows GoodRx's previous e-commerce launch with Opill, the first over-the-counter birth control pill, demonstrating the company's commitment to simplifying healthcare access. GoodRx currently serves nearly 30 million consumers and over one million healthcare professionals annually.

GoodRx (Nasdaq: GDRX), the leading medication savings platform in the U.S., has announced two key executive appointments. Aaron Crittenden has been named President of Rx Marketplace, while Scott Pope, PharmD, becomes Chief Pharmacy Officer and Head of Clinical Engagement.

Crittenden, who joined GoodRx in 2020, will manage the Rx Marketplace offering and work with retail pharmacy, PBM, employer, and manufacturer partners. As former Head of Manufacturer Solutions and Chief Revenue Officer, he helped grow revenue to over $100M. Pope brings nearly 30 years of healthcare experience and will oversee relationships with healthcare professionals, including marketing and product development.

GoodRx serves nearly 30 million consumers and over one million healthcare professionals annually. Since 2011, the platform has helped Americans save over $85 billion on medication costs by connecting consumers, healthcare professionals, payers, PBMs, pharma manufacturers, and retail pharmacies.

GoodRx (GDRX) has released a report revealing significant gender disparities in prescription medication costs. In 2024, women spent $8.8 billion more than men on out-of-pocket prescription costs, representing a 30% higher expenditure.

Key findings show women spent nearly $40 billion in total out-of-pocket prescription costs, with female-specific conditions exceeding $1.5 billion. The gender gap is most pronounced among women aged 18-44, who spend up to 64% more than men of the same age group. Women also outspend men significantly on mental health treatments, paying 113% more for depression medications and 103% more for anxiety treatments.

To address this disparity, GoodRx offers savings at over 70,000 pharmacies nationwide, including discounts up to 43% on fertility treatments and special pricing for menopause therapies ($99-$249 range).

GoodRx Holdings (NASDAQ: GDRX) has reported its Q4 and full-year 2024 financial results. For FY2024, the company achieved revenue of $792.3 million, a 6% increase from the previous year, with a net income of $16.4 million and a net income margin of 2.1%.

Key financial metrics include Adjusted EBITDA of $260.2 million with a 32.8% margin, and net cash from operations of $183.9 million. The company's prescription transactions revenue grew 5% to $577.5 million, while pharma manufacturer solutions revenue increased 26% to $107.2 million. However, subscription revenue decreased 8% to $86.5 million.

The company maintains a strong financial position with cash and cash equivalents of $448.3 million and total debt of $500.0 million. GoodRx serves nearly 30 million consumers and over one million healthcare professionals annually, having helped Americans save over $85 billion on medication costs since 2011.

GoodRx (Nasdaq: GDRX) has announced that its drug savings platform on AWS has earned HITRUST i1 Certification for 2025, validating its commitment to data protection and cybersecurity. The certification covers AWS data centers in California, Ohio, Oregon, and Virginia, demonstrating the company's adherence to specific security standards and controls against current and emerging threats.

The certification requires annual third-party audits and reinforces GoodRx's position in healthcare data protection. As the leading medication savings platform in the U.S., GoodRx serves nearly 30 million consumers and over one million healthcare professionals annually. Since 2011, the company has helped Americans save over $75 billion on medication costs by connecting consumers, healthcare professionals, payers, PBMs, pharma manufacturers, and retail pharmacies.